Journal article

Expanding the use of primaquine for the radical cure of Plasmodium vivax

Abstract:: There is currently strong impetus for global malaria eradication with many National Malaria Control Programs setting ambitious elimination targets. Whilst intensified malaria control efforts have reduced the burden of falciparum malaria significantly, the fragile gains made thus far remain vulnerable to the threat of emergence and spread of multidrug resistant parasites. Outside of Sub-Saharan Africa, the decline in falciparum malaria has also been shadowed by a rise in the proportion of malaria due to P. vivax, which is now the predominant cause of malaria in these regions. Vivax malaria is more difficult to eradicate than P. falciparum because it can form dormant liver stages (hypnozoites) that reactivate periodically, causing recurrent infections (relapses) and further transmission.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Price, R. N., & Douglas, N. M. (2018). Expanding the use of primaquine for the radical cure of Plasmodium vivax. Clinical Infectious Diseases, 67(7), 1008–1009.

MLA Style

Price, RN, and NM Douglas. “Expanding the Use of Primaquine for the Radical Cure of Plasmodium Vivax.” Clinical Infectious Diseases, vol. 67, no. 7, 2018, pp. 1008–09.

Chicago Style

Price, RN, and NM Douglas. 2018. “Expanding the Use of Primaquine for the Radical Cure of Plasmodium Vivax.” Clinical Infectious Diseases 67 (7): 1008–9.
Print

Access Document

Files:: Price and Douglas, Expanding the use of primaquine for the rad...

(Preview, Accepted manuscript, pdf, 361.3KB, Terms of use)

Publisher copy:: 10.1093/cid/ciy236

Authors

+ Price, RN More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: NDM; Tropical Medicine
Role:: Author
ORCID:: 0000-0003-2000-2874

+ Douglas, NM More by this author

Role:: Author

+ Wellcome Trust More from this funder

Grant:: Senior Research Fellowship

Publisher:: Oxford University Press
Journal:: Clinical Infectious Diseases More from this journal
Volume:: 67
Issue:: 7
Pages:: 1008–1009
Publication date:: 2018-03-24
Acceptance date:: 2018-03-24
DOI:: 10.1093/cid/ciy236
EISSN:: 1537-6591
ISSN:: 1058-4838
Pmid:: 29590343

Language:: English
Keywords:: Journal Article
Pubs id:: pubs:834097
UUID:: uuid:f0e6861b-1aa0-4ee6-b2dc-00a8b10f3e47
Local pid:: pubs:834097
Source identifiers:: 834097
Deposit date:: 2018-04-11
ARK identifier:: ark:/29072/ora_f0e6861b1aa04ee6b2dc00a8b10f3e47

Terms of use

Copyright holder:: Price and Douglas
Copyright date:: 2018
Notes:: © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP